New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›First Trust›FBT
ETF screener
FBT
IE00BL0L0H60
Passive ETFEquity

FBT ETF · First Trust NYSE Arca Biotechnology UCITS ETF

The FBT Exchange Traded Fund (ETF) is provided by First Trust. It is built to track an index: NYSE Arca Biotechnology Index. The FBT ETF provides physical exposure, so by buying it you actually own parts of all the 30 underlying holdings. The dividend policy is capitalization.
Last update Today at 9:54 AM UTC
LIVE
CLOSED
This fund is part ofUS Health Care1M perf.+13.74%
Last price
£2,354.30
+0.67%
1M perf.
+15.47%
1M flows
-€423K
AuM
€12M
TER
0.6%
Rating
FBT
£2,354.30
+0.67%

Performance & flows

Segment for quartile rank
April 7, 2026 → July 3, 2026
0-5%0%5%10%15%20%25%30%MAYJUNJULMAYJUNJUL
Create a free account to view the flows graph
FBT
$31.29
+26.99%
US Health Care
+12.88%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
+15.47%
icon
+26.99%
icon
+54.99%
icon
+68.02%
icon
+47.25%
icon
+3.01%
+3.01%
+23.92%
icon
Flows

Key fund info

Segment for quartile rank
Main characteristics
ISIN
IE00BL0L0H60
AuM
€12M
icon
TER
0.6%
icon
Replication rating
icon
More details
NAV
7/3/2026
$31.26
1D NAV change
-0.01%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
30
Inception date
5/27/2020
Jurisdiction
Ireland
Distribution
United Kingdom
Finland
Netherlands
Norway
Portugal
Legal structure
Open-end Investment Company
Base currency
USD
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The Fund investment seeks results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM (the "Index")
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Similar ETFs

FBT
1M perf.
+13.02%
TER
0.54%
FBT
1M perf.
+18.00%
TER
0.71%
PBE
1M perf.
+14.98%
TER
0.58%
EKG
1M perf.
+16.40%
TER
0.65%
CURE
1M perf.
+16.25%
TER
0.35%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
+26.99%
icon
+54.99%
icon
+68.02%
icon
+47.25%
icon
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
84.42%
Ireland
3.79%
Netherlands
3.13%
Germany
3.01%
Denmark
2.80%
Switzerland
2.79%
Sectors
Healthcare
99.94%
Diversification
Total weight of top 15 holdings out of 30
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:
1-year trailing difference
As of June 30, 2026
Create a free account to view the replication graph
FBT
N/A
Replication quality
Calculated over 12m, as of June 30, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model

Issuer

First Trust
First Trust ID Card
Number of funds
413
Total AuM
€247.42B
Expense ratio range
0.15% - 12.44%
Average expense ratio
0.7916%

Frequently asked questions about FBT

What does First Trust NYSE Arca Biotechnology UCITS ETF, FBT, invest in?

FBT is a Passive ETF. This ETF provides exposure to Equally Weighted US Biotechnology Equities.

Which benchmark or index does FBT replicate?

FBT tracks the NYSE Arca Biotechnology NTR Index - USD, through a full replication replication method.

What is the Total Expense ratio (TER) of FBT?

FBT carries a total expense ratio (TER) of 0.6%, indicating the annual cost for holding the fund.

When was FBT launched?

FBT was introduced to the market on May 27, 2020. It trades on United Kingdom, among other exchanges

Who is the ETF issuer of FBT?

First Trust NYSE Arca Biotechnology UCITS ETF, FBT, is provided by First Trust. Learn more about First Trust here.

What is the current assets under management (AUM) of FBT?

FBT oversees €12M in assets as of July 3, 2026.

How has FBT performed lately?

Based on data from July 3, 2026, FBT returned 15.47% over the past month, 26.99% over the last three months and 23.92% year-to-date.

What are the latest inflows or outflows for FBT?

As of July 3, 2026, FBT recorded net flows of -€408K over the last month and -€1.5M year-to-date.

Does FBT distribute dividends?

FBT follows a capitalizing, meaning it reinvests income within the fund.

What are the main country or region exposures of FBT?

As of May 31, 2026, FBT has significant geographic allocations in USA, Ireland and Netherlands.

In which sector or theme does FBT invest in?

As of May 31, 2026, FBT focuses largely on Healthcare.

How many securities does FBT hold and how diversified is it?

As of May 31, 2026, FBT holds 30 positions in its portfolio, with 57.44% of assets concentrated in its top 15 holdings.

What are the main positions in FBT?

As of May 31, 2026, FBT top three holdings include Corcept Therapeutics, Inc., Bruker Corp. and Veracyte, Inc..

What is the base currency of FBT?

The base currency of FBT is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight